Patient Characteristics | All n = 2882 | Dabigatran n = 2096 (72.7%) | Rivaroxaban n = 571 (19.8%) | Apixaban n = 215 (7.5%) | p |
---|---|---|---|---|---|
Age (mean + SD) | 67.4 (9.5) | 66.9 (9.3) | 67.3 (9.7) | 73.1 (8.8) | <0.01 |
Male (%) | 2792 (96.9) | 2035 (97.1) | 552 (96.7) | 205 (95.4) | 0.32 |
White Race (%) | 2383 (82.7) | 1735 (82.8) | 467 (81.8) | 181 (84.2) | 0.72 |
Hypertension (%) | 2556 (88.7) | 1874 (89.4) | 503 (88.1) | 179 (83.3) | 0.03 |
Congestive Heart Failure (%) | 852 (29.6) | 624 (29.8) | 173 (30.3) | 55 (25.6) | 0.41 |
Diabetes Mellitus (%) | 1398 (48.5) | 1036 (49.4) | 270 (47.3) | 92 (42.8) | 0.15 |
Cerebrovascular Accident (%) | 321 (11.1) | 240 (11.5) | 63 (11.0) | 18 (8.4) | 0.41 |
Prior Myocardial Infarction (%) | 391 (13.6) | 269 (12.8) | 89 (15.6) | 33 (15.4) | 0.16 |
Peripheral Arterial Disease (%) | 280 (9.7) | 201 (9.6) | 53 (9.3) | 26 (12.1) | 0.45 |
Peripheral Arterial Disease (%) | 2.9 (1.1) | 2.9 (1.0) | 3.0 (1.1) | 3.2 (1.2) | <0.01 |
CHA2DS2-VASc (mean + SD) | 2.9 (1.1) | 2.9 (1.0) | 3.0 (1.1) | 3.2 (1.2) | <0.01 |
Adherence | |||||
Mean (SD) pill count per dispensed supply | 38.1 (20.9) | 38.2 (20.8) | 38.2 (22.0) | 36.4 (18.7) | <0.01 |
Proportion of Days Covered (mean + SD) | 0.85 (0.19) | 0.84 (0.20) | 0.86 (0.18) | 0.89 (0.14) | <0.01 |
PDC < 80% n (%) | 796 (27.6%) | 604 (28.8%) | 143 (25.0%) | 49 (22.8%) | 0.05 |